<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Appl Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Appl. Genet</journal-id>
      <journal-title-group>
        <journal-title>Journal of Applied Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1234-1983</issn>
      <issn pub-type="epub">2190-3883</issn>
      <publisher>
        <publisher-name>Springer Berlin Heidelberg</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25820994</article-id>
      <article-id pub-id-type="pmc">4543405</article-id>
      <article-id pub-id-type="publisher-id">281</article-id>
      <article-id pub-id-type="doi">10.1007/s13353-015-0281-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Human Genetics &#x2022; Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fundus albipunctatus: review of the literature and report of a novel <italic>RDH5</italic> gene mutation affecting the invariant tyrosine (p.Tyr175Phe)</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Skorczyk-Werner</surname>
            <given-names>Anna</given-names>
          </name>
          <address>
            <email>aniaskorczyk@poczta.onet.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paw&#x142;owski</surname>
            <given-names>Przemys&#x142;aw</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Michalczuk</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Warowicka</surname>
            <given-names>Alicja</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wawrocka</surname>
            <given-names>Anna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wicher</surname>
            <given-names>Katarzyna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bakunowicz-&#x141;azarczyk</surname>
            <given-names>Alina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krawczy&#x144;ski</surname>
            <given-names>Maciej R.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Medical Genetics, Poznan University of Medical Sciences, 8, Rokietnicka Street, 60-806 Pozna&#x144;, Poland </aff>
        <aff id="Aff2"><label/>Department of Pediatric Ophthalmology and Strabismus, Medical University of Bialystok, 17, Waszyngtona Street, 15-275 Bia&#x142;ystok, Poland </aff>
        <aff id="Aff3"><label/>Center for Medical Genetics &#x201C;Genesis&#x201D;, 4, Grudzieniec Street, 60-601 Pozna&#x144;, Poland </aff>
        <aff id="Aff4"><label/>NanoBioMedical Centre, Adam Mickiewicz University, 85, Umultowska Street, 61-614 Pozna&#x144;, Poland </aff>
      </contrib-group>
      <author-notes>
        <fn fn-type="com">
          <p>Communicated by: Michal Witt</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>28</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2015</year>
      </pub-date>
      <volume>56</volume>
      <issue>3</issue>
      <fpage>317</fpage>
      <lpage>327</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>11</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>26</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Fundus albipunctatus (FA) is a rare, congenital form of night blindness with rod system impairment, characterised by the presence of numerous small, white-yellow retinal lesions. FA belongs to a heterogenous group of so-called flecked retina syndromes. This disorder shows autosomal recessive inheritance and is caused mostly by mutations in the <italic>RDH5</italic> gene. This gene encodes the enzyme that is a part of the visual cycle, the 11-<italic>cis</italic> retinol dehydrogenase. This study is a brief review of the literature on FA and a report of the first molecular evidence for <italic>RDH5</italic> gene mutation in a Polish patient with this rare disorder. We present a novel pathogenic <italic>RDH5</italic> gene mutation in a 16-year-old female patient with symptoms of night blindness. The patient underwent ophthalmological examinations, including colour vision testing, fundus photography, automated visual field testing, full-field electroretinography (ERG) and spectral optical coherent tomography (SOCT). The patient showed typical FA ERG records, the visual field was constricted and fundus examination revealed numerous characteristic, small, white-yellowish retinal lesions. DNA sequencing of the <italic>RDH5</italic> gene coding sequence (exons 2&#x2013;5) enabled the detection of the homozygous missense substitution c.524A&#x2009;&gt;&#x2009;T (p.Tyr175Phe) in exon 3. This is the first report of <italic>RDH5</italic> gene mutation that affects the invariant tyrosine, one of the most conserved amino acid residues in short-chain alcohol dehydrogenases/reductases (SDRs), crucial for these enzymes&#x2019; activity. The location of this substitution, together with its predicted influence on the protein function, indicate that the p.Tyr175Phe mutation is the cause of FA in our patient.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Fundus albipunctatus (FA)</kwd>
        <kwd><italic>RDH5</italic> gene</kwd>
        <kwd>Mutation</kwd>
        <kwd>Invariant tyrosine</kwd>
        <kwd>Short-chain dehydrogenases/reductases (SDRs)</kwd>
        <kwd>Retinal pigment epithelium (RPE)</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Institute of Plant Genetics, Polish Academy of Sciences, Poznan 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <sec id="Sec2">
        <title>Clinical characterisation of fundus albipunctatus</title>
        <p>Fundus albipunctatus (FA; MIM 136880) is a rare, hereditary, in most cases stationary, retinal disease, which is characterised by impaired night vision and numerous small, white-yellowish retinal lesions placed throughout the retina, except the fovea (Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>). FA belongs to a heterogenous group of genetically determined flecked retina syndromes. The symptoms of these disorders include conditions characterised by multiple retinal yellowish-white lesions of various sizes and configuration, without vascular or optic nerve abnormalities. The group of flecked retina syndromes encompasses FA, retinitis punctata albescens, fundus flavimaculatus (Stargardt disease), familial drusen and fleck retina of Kandori, but far more diseases correspond to the rather vague definition of fleck retina syndromes (De Laey <xref ref-type="bibr" rid="CR8">1993</xref>; Walia et al. <xref ref-type="bibr" rid="CR59">2009</xref>). Moreover, there is a collection of diseases called white dots syndromes that can also be misdiagnosed with flecked retina syndromes. White dots syndromes are characterised by white lesions in the retinal pigment epithelium (RPE) or choroidal layers. The aetiology of these disorders is unknown, but these syndromes are suspected to be inflammatory in nature and can be associated with uveitis (Matsumoto et al. <xref ref-type="bibr" rid="CR33">2007</xref>).</p>
        <p>FA is a form of congenital stationary night blindness. The symptoms of defective dark adaptation may not be perceptible to the affected person. The optic nerve heads and the retinal vessels show no signs of irregularity. The visual field and visual acuity examinations of patients suffering from FA do not detect any abnormalities unless a dim stimulus is used. Dim stimulus causes a worsening of visual acuity and a constriction of the visual field. The scotopic electroretinography (ERG) responses are reduced after a 30&#x2013;40-min period of dark adaptation, but typically normalise after prolonged dark adaptation (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>; Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Wang et al. <xref ref-type="bibr" rid="CR61">2012</xref>). The photopic responses are usually normal if FA is not accompanied by macular dystrophy. Although long-term follow-up usually shows no progression in rods dysfunction in patients with this form of night blindness, some patients, especially the elderly, reveal progressive cone dystrophy (Nakamura et al. <xref ref-type="bibr" rid="CR36">2000</xref>, <xref ref-type="bibr" rid="CR37">2003</xref>; Wada et al. <xref ref-type="bibr" rid="CR57">2001</xref>; Niwa et al. <xref ref-type="bibr" rid="CR39">2005</xref>). Full-field photopic electroretinograms of these individuals are usually severely reduced, a bull&#x2019;s eye maculopathy is often identified, and visual fields and acuity are impaired (Nakamura et al. <xref ref-type="bibr" rid="CR36">2000</xref><xref ref-type="bibr" rid="CR37">2003</xref>). Recently, it has been estimated that cone dysfunction can affect more than 30&#xA0;% of patients with FA (Niwa et al. <xref ref-type="bibr" rid="CR39">2005</xref>; Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Pras et al. <xref ref-type="bibr" rid="CR42">2012</xref>). Lid&#xE9;n and coworkers suggested that cone dystrophy may be either the result of impaired function of the RPE caused by a <italic>RDH5</italic> gene mutation or a direct consequence of a decreased supply of 11-<italic>cis</italic> retinal to the cones (Lid&#xE9;n et al. <xref ref-type="bibr" rid="CR28">2001</xref>).</p>
      </sec>
      <sec id="Sec3">
        <title>Genetic background</title>
        <p>FA shows an autosomal recessive inheritance pattern. In one family with this retinal disease, autosomal dominant or pseudodominant inheritance was suggested (Kranias et al. <xref ref-type="bibr" rid="CR25">1981</xref>). FA is caused almost exclusively by mutations in the 11-<italic>cis</italic> retinol dehydrogenase 5 (<italic>RDH5</italic>) gene (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>). However, mutations in two other genes, retinaldehyde binding protein 1 (<italic>RLBP1</italic>) and RPE-specific protein (<italic>RPE65</italic>), are also known to be associated with FA (Naz et al. <xref ref-type="bibr" rid="CR38">2011</xref>; Schatz et al. <xref ref-type="bibr" rid="CR48">2011</xref>). Retinaldehyde binding protein 1 is expressed in the RPE and M&#xFC;ller cells of the neuroretina, where it carries 11-<italic>cis</italic> retinol and 11-<italic>cis</italic> retinaldehyde as ligands (Sparkes et al. <xref ref-type="bibr" rid="CR54">1992</xref>). Only a few <italic>RLBP1</italic> gene mutations in patients with FA have been reported to date (Katsanis et al. <xref ref-type="bibr" rid="CR23">2001</xref>; Naz et al. <xref ref-type="bibr" rid="CR38">2011</xref>). Katsanis end coworkers (<xref ref-type="bibr" rid="CR23">2001</xref>) found a p.Arg150Gln mutation in the <italic>RLBP1</italic> gene in a consanguineous Saudi Arabian kindred with a retinal dystrophy phenotype that fulfilled the criteria of FA in younger individuals and retinitis punctata albescens in older patients. Two homozygous <italic>RLBP1</italic> gene mutations (p.Arg156* and p.Gly116Arg) have also been identified in two unrelated, consanguineous Pakistani families suffering from FA (Naz et al. <xref ref-type="bibr" rid="CR38">2011</xref>). RPE-specific protein (<italic>RPE65</italic>) is the isomerase of the visual cycle, catalysing the conversion of all-<italic>trans</italic> retinyl ester to 11-<italic>cis</italic> retinol (Moiseyev et al. <xref ref-type="bibr" rid="CR34">2005</xref>). To date, mutations in the <italic>RPE65</italic> gene associated with FA have only been reported in one paper. A compound heterozygote of IVS&#x2009;+&#x2009;5G&#x2009;&gt;&#x2009;A and c.344&#xA0;T&#x2009;&gt;&#x2009;C mutations in the <italic>RPE65</italic> gene was found in a patient with FA (Schatz et al. <xref ref-type="bibr" rid="CR48">2011</xref>).</p>
        <p>Most cases of FA are caused by mutations in the <italic>RDH5</italic> gene (Gonzalez-Fernandez et al. <xref ref-type="bibr" rid="CR13">1999</xref>). The <italic>RDH5</italic> gene encodes the enzyme that is a part of the visual cycle, the 11-<italic>cis</italic> retinol dehydrogenase (Simon et al. <xref ref-type="bibr" rid="CR51">1995</xref>). The retinoid (visual) cycle is an enzyme pathway that occurs to regenerate the visual chromophore following light exposure (Travis et al. <xref ref-type="bibr" rid="CR56">2007</xref>). 11-<italic>cis</italic> retinol dehydrogenase (<italic>RDH5</italic>) is predominantly expressed in the smooth endoplasmic reticulum of the RPE of the eye (Simon et al. <xref ref-type="bibr" rid="CR52">1996</xref>). RPE cells play multiple roles essential for visual function, such as involvement in the uptake and metabolic processing of retinoids in the visual cycle (Simon et al. <xref ref-type="bibr" rid="CR53">1999</xref>). <italic>RDH5</italic> has an important role in the molecular background of vision, as it catalyses the final step in the biosynthesis of 11-<italic>cis</italic> retinaldehyde, the universal chromophore of visual pigments (Simon et al. <xref ref-type="bibr" rid="CR51">1995</xref>). Absorption of a photon by an opsin pigment causes isomerisation of the chromophore from 11-<italic>cis</italic> retinaldehyde to all-<italic>trans</italic> retinaldehyde. After entering the RPE cell, all-<italic>trans</italic> retinol is transferred into all-<italic>trans</italic> retinyl esters, which are isomerised by <italic>RPE65</italic> (RPE-specific) protein into 11-<italic>cis</italic> retinol esters (11-<italic>cis</italic> retinol). Then, 11-<italic>cis</italic> retinol is transported through the subretinal space, where it is oxidated by the <italic>RDH5</italic> enzyme into 11-<italic>cis</italic> retinal (Simon et al. <xref ref-type="bibr" rid="CR51">1995</xref>; Wang et al. <xref ref-type="bibr" rid="CR61">2012</xref>).</p>
        <p>Retinol dehydrogenase 5 protein consists of 318 amino acids and is a member of the short-chain dehydrogenases/reductases (SDR) superfamily (Simon et al. <xref ref-type="bibr" rid="CR52">1996</xref>). This family encompasses at least 57 varied, well-characterised enzymes (J&#xF6;rnvall et al. <xref ref-type="bibr" rid="CR21">1995</xref>), which catalyse the metabolism of steroids, fatty acids, carbohydrates, amino acids and aromatic compounds (Marchler-Bauer et al. <xref ref-type="bibr" rid="CR32">2015</xref>). Although the amino acids sequence identity between the members of this large protein family is only at the 15&#x2013;30&#xA0;% level, there are two well-conserved regions within the enzymes&#x2019; sequences: the motif Gly-X-X-X-Gly-X-Gly, consisting of three glycines within a cofactor binding site for NAD(H) or NADP(H), and the amino acid motif Tyr-X-X-X-Lys, with an invariant tyrosine residue inside the active site. Like all the classical SDR enzymes, the <italic>RDH5</italic> amino acid sequence contains these two conserved domains: the motif Gly-Cys-Asp-Ser-Gly-Phe-Gly at the amino acid residues 35&#x2013;41 and the sequence encompassing the invariant tyrosine Tyr-Cys-Val-Ser-Lys at the residues 175&#x2013;179 (Persson et al. <xref ref-type="bibr" rid="CR41">1991</xref>; J&#xF6;rnvall et al. <xref ref-type="bibr" rid="CR21">1995</xref>; Simon et al. <xref ref-type="bibr" rid="CR53">1999</xref>). Retinol dehydrogenase 5 protein is highly conserved among species (Simon et al. <xref ref-type="bibr" rid="CR52">1996</xref>). The amino acid conservation of part of the active site (encompassing three conserved residues: Ser-163, Tyr-175, Lys-179) among <italic>RDH5</italic> of several species and three other short-chain dehydrogenases is shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>. <italic>RDH5</italic> is an integral membrane protein (Simon et al. <xref ref-type="bibr" rid="CR51">1995</xref>). It is composed of the N-terminus (18 amino acids) located within the membrane, the ectodomain encompassing the active site, which is present in the lumen of the smooth endoplasmic reticulum (SER) (residues 19&#x2013;288), the C-terminal membrane-spanning domain (289&#x2013;310 amino acids) and the C-terminal tail (311&#x2013;318 amino acids) located in the cytosol of the RPE (Simon et al. <xref ref-type="bibr" rid="CR53">1999</xref>; Ajmal et al. <xref ref-type="bibr" rid="CR3">2012</xref>). The different localisation of the <italic>RDH5</italic> domains within the RPE cell suggests that biosynthesis of 11-<italic>cis</italic> retinaldehyde is a compartmentalised process (Simon et al. <xref ref-type="bibr" rid="CR53">1999</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>The amino acid conservation of part of the active site (residues 157&#x2013;196 according to the numbering system of the <italic>RDH5</italic> protein) among <italic>RDH5</italic> of several species and three other short-chain dehydrogenases. The red frame indicates the invariant tyrosine, while the black frame indicates two other highly conserved residues involved in the catalytic mechanism: serine-163 and lysine-179. The abbreviation &#x2018;DH&#x2019; in the names of three aligned proteins&#x2019; sequences stands for &#x2018;dehydrogenase&#x2019;</p></caption><graphic xlink:href="13353_2015_281_Fig1_HTML" id="MO1"/></fig></p>
        <p>The <italic>RDH5</italic> gene is mapped on the chromosome 12q13-q14. The transcript (ENST00000257895) spans 1,269&#xA0;bp and contains five exons, including four coding exons (2&#x2013;5). The lengths of the coding exons are as follows: exon 2&#x2013;342&#xA0;bp (32&#xA0;bp of the 5&#x2032; untranslated region and 310&#xA0;bp translated sequence), exon 3&#x2013;259, exon 4&#x2013;164 and exon 5&#x2013;384&#xA0;bp (the translated part is 221&#xA0;bp) (Simon et al. <xref ref-type="bibr" rid="CR52">1996</xref>).</p>
      </sec>
    </sec>
    <sec id="Sec5" sec-type="materials|methods">
      <title>Materials and methods</title>
      <p>This study was conducted in accordance with the tenets of the Declaration of Helsinki. A 16-year-old female patient of Polish origin with clinical signs of night blindness was examined. The patient underwent colour vision testing, fundus photography, automated visual field testing (Humphrey&#x2013;Zeiss), full-field ERG and spectral optical coherent tomography (SOCT). The electrophysiological examinations included a full-field ERG protocol with the standard scotopic 20&#xA0;min dark adaptation and extended protocol with prolonged 120&#xA0;min of dark adaptation. The standard photopic ERG (30&#xA0;Hz white flicker stimulation) was performed after 10&#xA0;min of light adaptation.</p>
      <p>Voluntary informed consent for genetic examination was obtained not only from the mother of the patient (as the patient was underaged), but also from both parents and two sisters, who had their blood taken for segregation analysis for the presence of the novel mutation. Genomic DNA was extracted from peripheral blood using the conventional salting-out procedure. The coding regions of the <italic>RDH5</italic> gene (exons 2&#x2013;5) were amplified and sequenced to screen for disease-causing mutations in the patient. Eight primer pairs (including three pairs for amplifying exon 2, two for exons 3 and 5, and one pair for exon 4) were used following a previous report (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>). A fragment of exon 3 (primer pair designed 3b) was also amplified in both parents and two sisters of the proband. The polymerase chain reaction (PCR) products were purified with the use of ExoSAP-IT (Exonuclease I and Shrimp Alkaline Phosphatase Cleanup for PCR products, Affymetrix) and directly sequenced using Dye Terminator chemistry (v3.1 BigDye&#xAE; Terminator, Life Technologies). The sequencing products were separated on an ABI 3130xl capillary sequencer (Applied Biosystems). The obtained sequences were verified by comparing them to the reference sequence of the <italic>RDH5</italic> gene (GenBank NM_001199771.1) and screened for mutations. The in silico analysis using PROVEAN (Choi et al. <xref ref-type="bibr" rid="CR6">2012</xref>), SIFT (Kumar et al. <xref ref-type="bibr" rid="CR26">2009</xref>) and PolyPhen-2 (Adzhubei et al. <xref ref-type="bibr" rid="CR2">2010</xref>) software was performed to assess the possible functional effect of the novel missense mutation.</p>
    </sec>
    <sec id="Sec6" sec-type="results">
      <title>Results</title>
      <sec id="Sec7">
        <title>Family history</title>
        <p>The patient has three sisters. The younger sister suffers from astigmatism, while the mother and the two older sisters had no ophthalmologic problems. In both the proband&#x2019;s father&#x2019;s eyes, presenile cataract was revealed at the age of 38 years. He suffered from retinal detachment in the right eye later on. The first pregnancy of the patient&#x2019;s mother ended with a stillbirth (pedigree, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Pedigree and genotypes at the <italic>RDH5</italic> gene nucleotide position 524 of the family with the c.524A&#x2009;&gt;&#x2009;T mutation. The mutation is marked with red &#x2018;M&#x2019; letter, while the blue &#x2018;+&#x2019; symbol indicates a wild-type allele. The parents and two sisters of the proband were involved in the exon 3 sequencing analysis</p></caption><graphic xlink:href="13353_2015_281_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec8">
        <title>Clinical status</title>
        <p>Visual acuity and colour vision in the patient were normal. The examination of the anterior segment and the pupillary reflexes showed no abnormalities. An eye fundus examination revealed numerous small white-yellowish retinal lesions mainly in the upper quadrants of the retina (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Examination of the visual field revealed its peripheral constriction to approximately 10&#x2013;20&#xB0;. A full-field electroretinogram showed significantly reduced scotopic responses after the standard period of 20&#x2013;30&#xA0;min dark adaptation (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a). However, after a prolonged 120&#xA0;min of dark adaptation, rod responses normalised (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b). Photopic responses in all examinations were normal. The high-definition SOCT showed no abnormalities of the central macular thickness in either eye, but local modulations of the RPE and IS/OS (inner segment&#x2013;outer segment) junctions corresponding with retinal flecks were identified.<fig id="Fig3"><label>Fig. 3</label><caption><p>Fundus examination. <bold>a</bold> The right eye of a healthy individual, <bold>b</bold> The right eye of the patient with the c.524A&#x2009;&gt;&#x2009;T mutation in the <italic>RDH5</italic> gene. Numerous small, white-yellowish retinal lesions are located in the upper segments of the retina</p></caption><graphic xlink:href="13353_2015_281_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>Comparison of scotopic responses after 30 and 120&#xA0;min of dark adaptation: <italic>RE</italic>, right eye; <italic>LE</italic>, left eye. <bold>a</bold> The reduction of scotopic responses (DA 0.009 cdxs/m<sup>2</sup>) (b-wave amplitude RE: 26.68&#xA0;&#x3BC;V, LE: 26.53&#xA0;&#x3BC;V, normal 260&#x2009;&#xB1;&#x2009;151.4&#xA0;&#x3BC;V), standard electroretinography (ERG) response (3 cdxs/m<sup>2</sup>) on the borderline after 30&#xA0;min of dark adaptation. <bold>b</bold> The normalisation of scotopic responses after 120&#xA0;min of scotopic adaptation (b-wave amplitude RE: 259.1&#xA0;&#x3BC;V, LE: 378.2&#xA0;&#x3BC;V)</p></caption><graphic xlink:href="13353_2015_281_Fig4_HTML" id="MO4"/></fig></p>
      </sec>
      <sec id="Sec9">
        <title>Genetic analysis</title>
        <p>As the clinical findings, especially characteristic eye fundus appearance, indicated a suspicion of FA, searching for a mutation in the <italic>RDH5</italic> gene seemed to be the most appropriate strategy. Bidirectional sequencing of the <italic>RDH5</italic> gene coding region (exons 2&#x2013;5) revealed a homozygous mutation c.524A&#x2009;&gt;&#x2009;T in exon 3. This transversion changes codon UAC to UUC, which results in the substitution of polar tyrosine to non-polar phenylalanine at amino acid position 175 (p.Tyr175Phe) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). The in silico analysis of the predicted influence of the p.Tyr175Phe substitution on protein function with the use of PROVEAN software (the tolerance index score was &#x2212;3.900), as well as SIFT software (tolerance index score 0.00), revealed that this amino acid change is deleterious. The in silico analysis using PolyPhen-2 software predicted the mutation to be probably damaging (score of 1). The c.524A&#x2009;&gt;&#x2009;T variant was not found in a control cohort annotated in the Exome Variant Server (EVS) database (Exome Variant Server <xref ref-type="bibr" rid="CR11">2015</xref>) nor in the 1000 Genomes Project database (1000 Genomes Project Consortium <xref ref-type="bibr" rid="CR1">2012</xref>). The segregation analysis of the mutation in the proband&#x2019;s family revealed that both parents and one of the proband&#x2019;s sisters are heterozygous carriers of the c.524A&#x2009;&gt;&#x2009;T substitution (pedigree, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>A chromatogram showing the c.524A&#x2009;&gt;&#x2009;T mutation in the <italic>RDH5</italic> gene. <bold>a</bold> The wild-type nucleotide sequence and the wild-type protein sequence. The orange frame indicates the most conservative element between short-chain alcohol dehydrogenases, located within the active site of the enzyme. Invariant tyrosine is labelled blue and indicated with the red frame. <bold>b</bold> The nucleotide sequence of the heterozygous parent. <bold>c</bold> The sequence of the patient with c.524A&#x2009;&gt;&#x2009;T mutation and truncated protein sequence</p></caption><graphic xlink:href="13353_2015_281_Fig5_HTML" id="MO5"/></fig></p>
      </sec>
      <sec id="Sec10">
        <title>Mutations in the <italic>RDH5</italic> gene: review of the literature</title>
        <p>Since 1999, when Yamamoto et al. described the mutations in the <italic>RDH5</italic> gene in two unrelated patients suffering from FA (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>), there have been reports of missense, in-frame and frameshift mutations (Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>). To date, more than 40 mutations in the <italic>RDH5</italic> gene have been reported, and most of them are missense variants (Nakamura et al. <xref ref-type="bibr" rid="CR36">2000</xref>; Driessen et al. <xref ref-type="bibr" rid="CR10">2001</xref>; Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Ajmal et al. <xref ref-type="bibr" rid="CR3">2012</xref>; Wang et al. <xref ref-type="bibr" rid="CR61">2012</xref>; Waldron and Medefindt <xref ref-type="bibr" rid="CR58">2014</xref>; Stenson et al. <xref ref-type="bibr" rid="CR55">2014</xref>). The list of <italic>RDH5</italic> gene mutations identified in patients with FA together with the regions of the protein affected by these changes is shown in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. The <italic>RDH5</italic> gene mutations have been identified mostly in homozygotic or compound heterozygotic forms, but a few variants (p.Arg19Gly, p.Arg191Gln and p.Arg278Gln) have been found as single heterozygous mutations (Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Pras et al. <xref ref-type="bibr" rid="CR42">2012</xref>). There seems to be no hot spot in the gene, as the reported mutations are distributed across the entire <italic>RDH5</italic> coding sequence. The mutations identified affect the entire protein, except the N-terminus, with most mutations located in the longest domain: lumenal ectodomain (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). The analyses of biochemical defects in <italic>RDH5</italic> mutants associated with FA revealed that all the mutations tested (marked with &#x2018;+&#x2019; in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) affect the stability and expression level of the protein and result in subcellular mislocalisation. Moreover, loss of enzymatic activity in vitro and in vivo has been observed for almost all the constructed mutants (except the mutant with amino acid change p.Ala294Pro located in the C-terminal domain) (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>; Cideciyan et al. <xref ref-type="bibr" rid="CR7">2000</xref>; Lid&#xE9;n et al. <xref ref-type="bibr" rid="CR28">2001</xref>). Even in the absence of the enzyme activity caused by many <italic>RDH5</italic> mutations, night vision regenerates after prolonged dark adaptation in patients with FA. This fact can be explained by the results of the studies on Rdh knockout mice models (Driessen et al. <xref ref-type="bibr" rid="CR9">2000</xref>; Kim et al. <xref ref-type="bibr" rid="CR24">2005</xref>). Driessen and coworkers revealed that transgenic mice missing the <italic>RDH5</italic> gene display delayed dark adaptation, but only at a very high bleach level. The studies on Rdh5 and Rdh11 knockout mice revealed that one more enzyme, RDH11, appeared to have an important role in regenerating the chromophore. These results indicate that both RDH5 and RDH11 contribute to 11-<italic>cis</italic> retinal production (Driessen et al. <xref ref-type="bibr" rid="CR9">2000</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<italic>RDH5</italic> mutations identified in patients with fundus albipunctatus (FA)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Exon/intron</th><th>Nucleotide position</th><th>Amino acid residue</th><th>Region of the protein</th><th>Mutants analysis<sup>a</sup>
</th><th>Reference</th></tr></thead><tbody><tr><td>Exon 2</td><td>c.55A&#x2009;&gt;&#x2009;G</td><td>p.Arg19Gly</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 2</td><td>c.71_74delTGCC</td><td>p.Leu24Profs*36</td><td>Ectodomain</td><td>&#x2212;</td><td>Pras et al. (<xref ref-type="bibr" rid="CR42">2012</xref>)</td></tr><tr><td>Exon 2</td><td>c.95delT</td><td>p.Phe32Serfs*29</td><td>Ectodomain</td><td>&#x2212;</td><td>Schatz et al. (<xref ref-type="bibr" rid="CR47">2010</xref>)</td></tr><tr><td>Exon 2</td><td>c.98&#xA0;T&#x2009;&gt;&#x2009;C</td><td>p.Ile33Thr</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 2</td><td>c.98&#xA0;T&#x2009;&gt;&#x2009;A</td><td>p.Ile33Asn</td><td>Ectodomain</td><td>&#x2212;</td><td>R&#xFC;ther et al. (<xref ref-type="bibr" rid="CR45">2004</xref>)</td></tr><tr><td>Exon 2</td><td>c.103G&#x2009;&gt;&#x2009;A</td><td>p.Gly35Ser</td><td>Ectodomain, the conserved cofactor binding motif</td><td>+</td><td>Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>); Wada et al. (<xref ref-type="bibr" rid="CR57">2001</xref>)</td></tr><tr><td>Exon 2</td><td>c.124C&#x2009;&gt;&#x2009;T</td><td>p.Arg42Cys</td><td>Ectodomain</td><td>&#x2212;</td><td>Niwa et al. (<xref ref-type="bibr" rid="CR39">2005</xref>)</td></tr><tr><td>Exon 2</td><td>c.129delT</td><td>p.Leu44Trpfs*17</td><td>Ectodomain</td><td>&#x2212;</td><td>Driessen et al. (<xref ref-type="bibr" rid="CR10">2001</xref>)</td></tr><tr><td>Exon 2</td><td>c.160C&#x2009;&gt;&#x2009;T</td><td>p.Arg54*</td><td>Ectodomain</td><td>&#x2212;</td><td>Pras et al. (<xref ref-type="bibr" rid="CR42">2012</xref>)</td></tr><tr><td>Exon 2</td><td>c.175&#xA0;T&#x2009;&gt;&#x2009;A</td><td>p.Cys59Ser</td><td>Ectodomain</td><td>&#x2212;</td><td>Wang et al. (<xref ref-type="bibr" rid="CR61">2012</xref>)</td></tr><tr><td>Exon 2</td><td>c.214insGTGG</td><td>p.Val71fs*86</td><td>Ectodomain</td><td>&#x2212;</td><td>Driessen et al. (<xref ref-type="bibr" rid="CR10">2001</xref>)</td></tr><tr><td>Exon 2</td><td>c.218C&#x2009;&gt;&#x2009;T</td><td>p.Ser73Phe</td><td>Ectodomain</td><td>+</td><td>Yamamoto et al. (<xref ref-type="bibr" rid="CR62">1999</xref>)</td></tr><tr><td>Exon 2</td><td>c.285G&#x2009;&gt;&#x2009;A</td><td>p.Trp95*</td><td>Ectodomain</td><td>&#x2212;</td><td>Wang et al. (<xref ref-type="bibr" rid="CR61">2012</xref>)</td></tr><tr><td>Intron 2</td><td>c.310&#x2009;+&#x2009;1G&#x2009;&gt;&#x2009;A</td><td>&#x2013;</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 3</td><td>c.319G&#x2009;&gt;&#x2009;C</td><td>p.Gly107Arg</td><td>Ectodomain</td><td>&#x2212;</td><td>Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>); Sato et al. (<xref ref-type="bibr" rid="CR46">2004</xref>); Hotta et al. (<xref ref-type="bibr" rid="CR18">2003</xref>)</td></tr><tr><td>Exon 3</td><td>c.346G&#x2009;&gt;&#x2009;C</td><td>p.Gly116Arg</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 3</td><td>c.346_347insGCA</td><td>p.Gly116_Ile117insSer</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 3</td><td>c.382G&#x2009;&gt;&#x2009;A</td><td>p.Asp128Asn</td><td>Ectodomain</td><td>+</td><td>Iannaccone et al. (<xref ref-type="bibr" rid="CR19">2007</xref>); Schatz et al. (<xref ref-type="bibr" rid="CR47">2010</xref>); Pras et al. (<xref ref-type="bibr" rid="CR42">2012</xref>)</td></tr><tr><td>Exon 3</td><td>c.394&#xA0;G&#x2009;&gt;&#x2009;A</td><td>p.Val132Met</td><td>Ectodomain</td><td>&#x2212;</td><td>Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>)</td></tr><tr><td>Exon 3</td><td>c.416G&#x2009;&gt;&#x2009;T</td><td>p.Gly139Val</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 3</td><td>c.469C&#x2009;&gt;&#x2009;T</td><td>p.Arg157Trp</td><td>Ectodomain</td><td>+</td><td>Cideciyan et al. (<xref ref-type="bibr" rid="CR7">2000</xref>)</td></tr><tr><td>Exon 3</td><td>c.470G&#x2009;&gt;&#x2009;A</td><td>p.Arg157Gln</td><td>Ectodomain</td><td>&#x2212;</td><td>Hajali et al. (<xref ref-type="bibr" rid="CR15">2009</xref>); Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 3</td><td>c.490G&#x2009;&gt;&#x2009;T</td><td>p.Val164Phe</td><td>Ectodomain</td><td>&#x2212;</td><td>Yamamoto et al. (<xref ref-type="bibr" rid="CR63">2003</xref>)</td></tr><tr><td>Exon 3</td><td>c.500G&#x2009;&gt;&#x2009;A</td><td>p.Arg167His</td><td>Ectodomain</td><td>&#x2212;</td><td>Sekiya et al. (<xref ref-type="bibr" rid="CR49">2003</xref>)</td></tr><tr><td>Exon 3</td><td>c.524A&#x2009;&gt;&#x2009;T</td><td>p.Tyr175Phe</td><td>Ectodomain, the conserved motif within the active site, invariant tyrosine</td><td>&#x2212;</td><td>This study</td></tr><tr><td>Exon 3</td><td>c.530&#xA0;T&#x2009;&gt;&#x2009;G</td><td>p.Val177Gly</td><td>Ectodomain, the conserved motif within active site</td><td>&#x2212;</td><td>Kuroiwa et al. (<xref ref-type="bibr" rid="CR27">2000</xref>)</td></tr><tr><td>Exon 4</td><td>c.572G&#x2009;&gt;&#x2009;A</td><td>p.Arg191Gln</td><td>Ectodomain</td><td>&#x2212;</td><td>Pras et al. (<xref ref-type="bibr" rid="CR42">2012</xref>)</td></tr><tr><td>Exon 4</td><td>c.625C&#x2009;&gt;&#x2009;T</td><td>p.Arg209*</td><td>Ectodomain</td><td>&#x2212;</td><td>Schatz et al. (<xref ref-type="bibr" rid="CR47">2010</xref>)</td></tr><tr><td>Exon 4</td><td>c.689_690delCTinsGG</td><td>p.Pro230Arg</td><td>Ectodomain</td><td>&#x2212;</td><td>Wang et al. (<xref ref-type="bibr" rid="CR60">2008</xref>)</td></tr><tr><td>Exon 4</td><td>c.710A&#x2009;&gt;&#x2009;C</td><td>p.Tyr237Ser</td><td>Ectodomain</td><td/><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 4</td><td>c.712G&#x2009;&gt;&#x2009;T</td><td>p.Gly238Trp</td><td>Ectodomain</td><td>+</td><td>Yamamoto et al. (<xref ref-type="bibr" rid="CR62">1999</xref>); Gonzalez-Fernandez et al. (<xref ref-type="bibr" rid="CR13">1999</xref>); Hajali et al. (<xref ref-type="bibr" rid="CR15">2009</xref>); Iannaccone et al. (<xref ref-type="bibr" rid="CR19">2007</xref>)</td></tr><tr><td>Exon 4</td><td>c.718dupG</td><td>p.Ala240Glyfs*19</td><td>Ectodomain</td><td>&#x2212;</td><td>Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>)</td></tr><tr><td>Exon 4</td><td>c.718delG</td><td>p.Ala240Profs*7</td><td>Ectodomain</td><td>&#x2212;</td><td>Makiyama et al. (<xref ref-type="bibr" rid="CR31">2014</xref>)</td></tr><tr><td>Exon 5</td><td>c.758&#xA0;T&#x2009;&gt;&#x2009;G</td><td>p.Met253Arg</td><td>Ectodomain</td><td>&#x2212;</td><td>Ajmal et al. (<xref ref-type="bibr" rid="CR3">2012</xref>)</td></tr><tr><td>Exon 5</td><td>c.791&#xA0;T&#x2009;&gt;&#x2009;G</td><td>p.Val264Gly</td><td>Ectodomain</td><td>+</td><td>Hirose et al. (<xref ref-type="bibr" rid="CR17">2000</xref>)</td></tr><tr><td>Exon 5</td><td>c.801C&#x2009;&gt;&#x2009;G</td><td>p.Cys267Trp</td><td>Ectodomain</td><td>&#x2212;</td><td>Driessen et al. (<xref ref-type="bibr" rid="CR10">2001</xref>)</td></tr><tr><td>Exon 5</td><td>c.824_825delGA</td><td>p.Arg275Profs*60</td><td>Ectodomain</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr><tr><td>Exon 5</td><td>c.832C&#x2009;&gt;&#x2009;T</td><td>p.Arg278*</td><td>Ectodomain</td><td>&#x2212;</td><td>Liu et al. (<xref ref-type="bibr" rid="CR29">2015</xref>)</td></tr><tr><td>Exon 5</td><td>c.833G&#x2009;&gt;&#x2009;A</td><td>p.Arg278Gln</td><td>Ectodomain</td><td>&#x2212;</td><td>Pras et al. (<xref ref-type="bibr" rid="CR42">2012</xref>)</td></tr><tr><td>Exon 5</td><td>c.839G&#x2009;&gt;&#x2009;A</td><td>p.Arg280His</td><td>Ectodomain</td><td>+</td><td>Gonzalez-Fernandez et al. (<xref ref-type="bibr" rid="CR13">1999</xref>); Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>); Kuroiwa et al. (<xref ref-type="bibr" rid="CR27">2000</xref>); Sato et al. (<xref ref-type="bibr" rid="CR46">2004</xref>)</td></tr><tr><td>Exon 5</td><td>c.841&#xA0;T&#x2009;&gt;&#x2009;C</td><td>p.Tyr281His</td><td>Ectodomain</td><td>&#x2212;</td><td>Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>); Nakamura and Miyake (<xref ref-type="bibr" rid="CR35">2002</xref>)</td></tr><tr><td>Exon 5</td><td>c.880G&#x2009;&gt;&#x2009;C</td><td>p.Ala294Pro</td><td>C-terminal transmembrane domain</td><td>+</td><td>Gonzalez-Fernandez et al. (<xref ref-type="bibr" rid="CR13">1999</xref>); Schatz et al. (<xref ref-type="bibr" rid="CR47">2010</xref>)</td></tr><tr><td>Exon 5</td><td>c.913_917delGTGCT</td><td>p.Val305Hisfs*29</td><td>C-terminal transmembrane domain</td><td>&#x2212;</td><td>Ajmal et al. (<xref ref-type="bibr" rid="CR3">2012</xref>)</td></tr><tr><td>Exon 5</td><td>c.928delCinsGAAG</td><td>p.Leu310GluVal</td><td>C-terminal transmembrane domain</td><td>+</td><td>Nakamura et al. (<xref ref-type="bibr" rid="CR36">2000</xref>); Nakamura and Miyake (<xref ref-type="bibr" rid="CR35">2002</xref>); Sato et al. (<xref ref-type="bibr" rid="CR46">2004</xref>); Wang et al. (<xref ref-type="bibr" rid="CR60">2008</xref>); Liu et al. (<xref ref-type="bibr" rid="CR29">2014</xref>); Makiyama et al. (<xref ref-type="bibr" rid="CR31">2014</xref>)</td></tr><tr><td>Exon 5</td><td>c.955&#xA0;T&#x2009;&gt;&#x2009;C</td><td>p.*319Argext*32</td><td>C-terminal cytosolic tail</td><td>&#x2212;</td><td>Sergouniotis et al. (<xref ref-type="bibr" rid="CR50">2011</xref>)</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>&#x2018;+&#x2019; indicates that the mutants were constructed for this mutation and the analysis of biochemical defects was performed (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>; Cideciyan et al. <xref ref-type="bibr" rid="CR7">2000</xref>; Lid&#xE9;n et al. <xref ref-type="bibr" rid="CR28">2001</xref>); &#x2018;&#x2013;&#x2019; indicates that the mutants analysis have not been reported</p></table-wrap-foot></table-wrap></p>
        <p>High variability of the disease&#x2019;s phenotype is observed among patients with FA carrying <italic>RDH5</italic> mutations. They show a variable visual acuity and variation in the density of white flecks (from minimal white dots or even normal fundus to numerous larger coalescent spots) (Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Ajmal et al. <xref ref-type="bibr" rid="CR3">2012</xref>). Despite the observed phenotypic variability, the presence of white dots appeared to be a common feature in patients with FA. These retinal flecks are hypothesised to be the effect of an accumulation of toxic retinyl esters in the RPE as the result of 11-<italic>cis</italic> retinol dehydrogenase disruption (Driessen et al. <xref ref-type="bibr" rid="CR9">2000</xref>). However, it is known that, with increasing age in the patients with FA or after uveitis, the dots may fade and become smaller and discrete, especially in the far periphery of the fundus (Yamamoto et al. <xref ref-type="bibr" rid="CR63">2003</xref>; Imaizumi et al. <xref ref-type="bibr" rid="CR20">2005</xref>; Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>). Patients with mutations in the <italic>RDH5</italic> gene can manifest a non-progressive or progressive form of the disease. It has been reported that individuals with or without cone dystrophy also presented varying degrees of severity of FA (Nakamura et al. <xref ref-type="bibr" rid="CR36">2000</xref>, <xref ref-type="bibr" rid="CR37">2003</xref>; Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Ajmal et al. <xref ref-type="bibr" rid="CR3">2012</xref>). Moreover, different phenotypes have been observed in patients with the same mutation, for example, c.928delCinsGAAG (p.Leu310GluVal), which is the most commonly identified <italic>RDH5</italic> gene mutation (Nakamura et al. <xref ref-type="bibr" rid="CR36">2000</xref>, <xref ref-type="bibr" rid="CR37">2003</xref>; Nakamura and Miyake <xref ref-type="bibr" rid="CR35">2002</xref>; Sato et al. <xref ref-type="bibr" rid="CR46">2004</xref>; Pras et al. <xref ref-type="bibr" rid="CR42">2012</xref>; Ajmal et al. <xref ref-type="bibr" rid="CR3">2012</xref>).</p>
        <p>Therefore, based on the complete review of the literature, it is difficult to establish any valid correlation between the <italic>RDH5</italic> variants and the disease. There is no significant association between the localisation or the type of <italic>RDH5</italic> mutation with the severity of the disease phenotype (including electrophysiological observations or the presence/absence of cone dystrophy) (Sato et al. <xref ref-type="bibr" rid="CR46">2004</xref>; Niwa et al. <xref ref-type="bibr" rid="CR39">2005</xref>; Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Pras et al. <xref ref-type="bibr" rid="CR42">2012</xref>).</p>
      </sec>
    </sec>
    <sec id="Sec11" sec-type="discussion">
      <title>Discussion</title>
      <p>The differential diagnosis of flecked retina/white dots syndromes can be difficult using routine ophthalmological examination. In cases of FA with progressive cone dystrophy, signs and symptoms may be non-specific and lead to misdiagnosis. Small white-yellow retinal lesions could indicate the diagnosis of fundus flavimaculatus, familial dominant drusen or retinitis punctata albescens (De Laey <xref ref-type="bibr" rid="CR8">1993</xref>; Walia et al. <xref ref-type="bibr" rid="CR59">2009</xref>). Moreover, phenotypic variability in the fundus appearance of patients with FA has been described (Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>; Ajmal et al. <xref ref-type="bibr" rid="CR3">2012</xref>). Electrophysiological findings, together with the appropriate genetic analysis, appear to be crucial tools in the differential diagnosis of FA (Pras et al. <xref ref-type="bibr" rid="CR42">2012</xref>). Although decreased scotopic ERG responses could appear in many different conditions (retinitis punctata albescens, FA, FA with progressive cone dystrophy and Stargardt disease), their normalisation after 120&#xA0;min of dark adaptation is observed mostly in FA (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>) (Yamamoto et al. <xref ref-type="bibr" rid="CR62">1999</xref>; Kanski <xref ref-type="bibr" rid="CR23">2003</xref>). However, retinitis punctata albescens due to <italic>RLBP1</italic> mutation (Bothnia dystrophy) may be more difficult to distinguish, as in the early stages, there is phenotypic overlap with FA. Some patients with Bothnia dystrophy show a dramatic improvement in electroretinograms after prolonged dark adaptation (Burstedt et al. <xref ref-type="bibr" rid="CR5">2008</xref>; Gr&#xE4;nse et al. <xref ref-type="bibr" rid="CR14">2001</xref>), while some patients with FA may present a minimal change, even after several hours of dark adaptation (Sergouniotis et al. <xref ref-type="bibr" rid="CR50">2011</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Comparison of conditions with the symptom of small white-yellow retinal lesions</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Fundus albipunctatus</th><th>Fundus albipunctatus with progressive cone dystrophy</th><th>Retinitis punctata albescens</th><th>Fundus flavimaculatus (Stargardt disease)</th><th>Our patient</th></tr></thead><tbody><tr><td>Eye fundus</td><td>Numerous small white-yellow retinal lesions</td><td>Numerous small white-yellow retinal lesions</td><td>Numerous small white-yellow retinal lesions</td><td>Numerous fleck-like yellow retinal lesions</td><td>Numerous small white-yellow retinal lesions</td></tr><tr><td>Visual field</td><td>Normal</td><td>Can be constricted</td><td>Constricted</td><td>Can be constricted</td><td>Peripherally constricted</td></tr><tr><td>Retinal vessels</td><td>Normal</td><td>Normal</td><td>Attenuated</td><td>Can be attenuated</td><td>Normal</td></tr><tr><td>ERG</td><td>Depressed rods responses</td><td>Depressed rods responses</td><td>Depressed rods responses</td><td>Variable</td><td>Depressed rods responses</td></tr><tr><td>ERG after prolonged dark adaptation</td><td>Proper scotopic responses</td><td>Proper scotopic responses</td><td>Depressed scotopic response</td><td>Variable</td><td>Proper scotopic responses</td></tr><tr><td>mfERG</td><td>Normal</td><td>Reduced cones density</td><td>Normal</td><td>Decreased central</td><td>Reduced cones density in peripheral rings</td></tr></tbody></table></table-wrap></p>
      <p>Optimistically, recent studies provide hope for the successful treatment of patients diagnosed with FA. Studies on mouse models of FA demonstrated a significant improvement in rod and cone visual function after treatment with 9-<italic>cis</italic> retinal (Maeda et al. <xref ref-type="bibr" rid="CR30">2006</xref>). Moreover, the latest pilot clinical testing on a group of patients with FA revealed that treatment with 9-<italic>cis</italic>-&#x3B2;-carotene as a food supplement led to a considerable visual improvement. It is very promising, as there has been no reported treatment resulting in a significant improvement in the visual functions in patients with retinal dystrophy to date and, what is more, this approach will also be helpful for some patients with retinitis pigmentosa (Rotenstreich et al. <xref ref-type="bibr" rid="CR43">2010</xref>, <xref ref-type="bibr" rid="CR44">2013</xref>).</p>
      <p>Genetic analysis of the <italic>RDH5</italic> gene (exons 2&#x2013;5) in our patient revealed a novel, homozygous mutation c.524A&#x2009;&gt;&#x2009;T in exon 3. The change of the chemical properties of the substituted amino acids and the mutation&#x2019;s predicted influence on the protein function indicate that the p.Tyr175Phe mutation is probably pathogenic. Moreover, tyrosine at position 175 of the <italic>RDH5</italic> protein is localised within the active site of the enzyme, and was described as invariant tyrosine (Simon et al. <xref ref-type="bibr" rid="CR52">1996</xref>). It is known that invariant tyrosines are found in all short-chain alcohol dehydrogenases. The Tyr-X-X-X-Lys sequence motif, a part of the substrate binding (active) site, is the most conserved element in SDRs (Persson et al. <xref ref-type="bibr" rid="CR41">1991</xref>; J&#xF6;rnvall et al. <xref ref-type="bibr" rid="CR21">1995</xref>). To date, only one mutation in this highly conserved motif of the human <italic>RDH5</italic> enzyme (Tyr-Cys-Val-Ser-Lys) has been identified. It was a substitution of valine to glycine at amino acid position 177. This variant was found in a boy with FA, who was a compound heterozygote of p.Val177Gly and p.Arg280His (Kuroiwa et al. <xref ref-type="bibr" rid="CR27">2000</xref>), but also in a boy diagnosed with familial fleck retina with night blindness (a heterozygote of p.Val177Gly and p.Leu310GluVal) (Hayashi et al. <xref ref-type="bibr" rid="CR16">2006</xref>).</p>
      <p>The invariant tyrosine, together with the lysine at position 179 (of the human <italic>RDH5</italic>) within the conserved motif and serine-163 (shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>), are involved in the catalytic mechanism (as putative active site residues), but only tyrosine located within this sequence is rigidly conserved in the SDR superfamily (J&#xF6;rnvall et al. <xref ref-type="bibr" rid="CR21">1995</xref>; Filling et al. <xref ref-type="bibr" rid="CR12">2001</xref>; Oppermann et al. <xref ref-type="bibr" rid="CR40">2003</xref>). The role of the invariant tyrosine was analysed in the most studied member of the SDR superfamily: Drosophila alcohol dehydrogenase (ADH). Albalat and Gonz&#xE1;lez-Duarte (<xref ref-type="bibr" rid="CR4">1992</xref>) constructed a Drosophila alcohol dehydrogenase, in which the invariant tyrosine (at amino acid position 152) was substituted by phenylalanine. Drosophila alcohol dehydrogenase-phenylalanine-152 revealed no enzymatic activity. Therefore, it is very likely that substitution of the invariant tyrosine to phenylalanine in human retinol dehydrogenase (<italic>RDH5</italic>) protein would have a similarly damaging effect to that reported in Drosophila ADH.</p>
      <p>The segregation analysis of the presence of the c.524A&#x2009;&gt;&#x2009;T mutation in the family studied was found to be consistent with the autosomal recessive mode of inheritance. It revealed that both the proband&#x2019;s parents are heterozygous carriers of this novel substitution. Therefore, it is highly probable that they are related. We did not confirm this assumption based on the exact pedigree data, but the parents&#x2019; families come from villages located in very close proximity.</p>
      <p>To conclude, we have presented a brief but complete review of the literature on FA, focusing on the genetic background of the disease. Our study expands the spectrum of <italic>RDH5</italic> mutations, as we also report the novel mutation in the 11-<italic>cis</italic> retinol dehydrogenase 5 gene. This study is the first report of a <italic>RDH5</italic> gene mutation that affects the invariant tyrosine, one of the most conserved amino acid residues in SDRs, crucial for these enzymes&#x2019; activity. The location of the substitution, together with the mutation&#x2019;s predicted influence on protein function, indicate that the p.Tyr175Phe mutation is probably pathogenic and can be recognised as the cause of FA. Moreover, we have presented the first molecular evidence for 11-<italic>cis</italic> retinol dehydrogenase 5 (<italic>RDH5</italic>) gene mutation in a Polish patient with this rare retinal disease. This study may also help clinicians to improve the difficult process of FA differential diagnosis, in which genetic analysis is an indispensable element, which would enable the correct treatment of patients.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This study was partially supported by a grant from the Polish Ministry of Science and Higher Education (806/N-NIEMCY/2010/0).</p>
      <sec id="FPar1">
        <title>Conflict of interest</title>
        <p>None.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <mixed-citation publication-type="other">1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56&#x2013;65. <ext-link ext-link-type="uri" xlink:href="http://www.1000genomes.org/">http://www.1000genomes.org</ext-link>. Accessed 11 February 2015</mixed-citation>
      </ref>
      <ref id="CR2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adzhubei</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Peshkin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ramensky</surname>
              <given-names>VE</given-names>
            </name>
            <name>
              <surname>Gerasimova</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kondrashov</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Sunyaev</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>A method and server for predicting damaging missense mutations</article-title>
          <source>Nat Methods</source>
          <year>2010</year>
          <volume>7</volume>
          <fpage>248</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
          <pub-id pub-id-type="pmid">20354512</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ajmal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Neveling</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Iqbal</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Azam</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>den Hollander</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Qamar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cremers</surname>
              <given-names>FP</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations in RDH5 cause fundus albipunctatus in two consanguineous Pakistani families</article-title>
          <source>Mol Vis</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>1558</fpage>
          <lpage>1571</lpage>
          <pub-id pub-id-type="pmid">22736946</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albalat</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez-Duarte</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Protein engineering of Drosophila alcohol dehydrogenase. The hydroxyl group of Tyr152 is involved in the active site of the enzyme</article-title>
          <source>FEBS Lett</source>
          <year>1992</year>
          <volume>308</volume>
          <fpage>235</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="doi">10.1016/0014-5793(92)81282-Q</pub-id>
          <pub-id pub-id-type="pmid">1505661</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burstedt</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Sandgren</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Golovleva</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wachtmeister</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Effects of prolonged dark adaptation in patients with retinitis pigmentosa of Bothnia type: an electrophysiological study</article-title>
          <source>Doc Ophthalmol</source>
          <year>2008</year>
          <volume>116</volume>
          <fpage>193</fpage>
          <lpage>205</lpage>
          <pub-id pub-id-type="doi">10.1007/s10633-007-9082-9</pub-id>
          <pub-id pub-id-type="pmid">17922155</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sims</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Predicting the functional effect of amino acid substitutions and indels</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e46688</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0046688</pub-id>
          <pub-id pub-id-type="pmid">23056405</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cideciyan</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Haeseleer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fariss</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Aleman</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Jang</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Verlinde</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Marmor</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Palczewski</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Rod and cone visual cycle consequences of a null mutation in the 11-cis-retinol dehydrogenase gene in man</article-title>
          <source>Vis Neurosci</source>
          <year>2000</year>
          <volume>17</volume>
          <fpage>667</fpage>
          <lpage>678</lpage>
          <pub-id pub-id-type="doi">10.1017/S0952523800175029</pub-id>
          <pub-id pub-id-type="pmid">11153648</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Laey</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Flecked retina disorders</article-title>
          <source>Bull Soc Belge Ophtalmol</source>
          <year>1993</year>
          <volume>249</volume>
          <fpage>11</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">7952338</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Driessen</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Winkens</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuhlmann</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Van Vugt</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Van Hooser</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Deutman</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Palczewski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ruether</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters</article-title>
          <source>Mol Cell Biol</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>4275</fpage>
          <lpage>4287</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.20.12.4275-4287.2000</pub-id>
          <pub-id pub-id-type="pmid">10825191</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Driessen</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Winkens</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kuhlmann</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Van Vugt</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Pinckers</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Deutman</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Null mutation in the human 11-cis retinol dehydrogenase gene associated with fundus albipunctatus</article-title>
          <source>Ophthalmology</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>1479</fpage>
          <lpage>1484</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(01)00640-6</pub-id>
          <pub-id pub-id-type="pmid">11470705</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <mixed-citation publication-type="other">Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA. Home page at: <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>. Accessed 11 February 2015</mixed-citation>
      </ref>
      <ref id="CR12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Filling</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nordling</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Benach</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Berndt</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Ladenstein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>J&#xF6;rnvall</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oppermann</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Structural role of conserved Asn179 in the short-chain dehydrogenase/reductase scaffold</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2001</year>
          <volume>289</volume>
          <fpage>712</fpage>
          <lpage>717</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.2001.6032</pub-id>
          <pub-id pub-id-type="pmid">11726206</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonzalez-Fernandez</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kurz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Newman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Conway</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Khani</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus</article-title>
          <source>Mol Vis</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>41</fpage>
          <pub-id pub-id-type="pmid">10617778</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gr&#xE4;nse</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Abrahamson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ponjavic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Andr&#xE9;asson</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological findings in two young patients with Bothnia dystrophy and a mutation in the RLBP1 gene</article-title>
          <source>Ophthalmic Genet</source>
          <year>2001</year>
          <volume>22</volume>
          <fpage>97</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1076/opge.22.2.97.2231</pub-id>
          <pub-id pub-id-type="pmid">11449319</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hajali</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Dryja</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Sweeney</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Lindeman</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis in a patient with fundus albipunctatus and atypical fundus changes</article-title>
          <source>Doc Ophthalmol</source>
          <year>2009</year>
          <volume>118</volume>
          <fpage>233</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1007/s10633-008-9151-8</pub-id>
          <pub-id pub-id-type="pmid">18949499</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Goto-Omoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gekka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ueoka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kitahara</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Compound heterozygous RDH5 mutations in familial fleck retina with night blindness</article-title>
          <source>Acta Ophthalmol Scand</source>
          <year>2006</year>
          <volume>84</volume>
          <fpage>254</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0420.2005.00575.x</pub-id>
          <pub-id pub-id-type="pmid">16637847</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirose</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morimura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okamoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fujikado</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tano</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the 11-cis retinol dehydrogenase gene in Japanese patients with Fundus albipunctatus</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>3933</fpage>
          <lpage>3935</lpage>
          <pub-id pub-id-type="pmid">11053296</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hotta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Terasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hida</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Macular dystrophy in a Japanese family with fundus albipunctatus</article-title>
          <source>Am J Ophthalmol</source>
          <year>2003</year>
          <volume>135</volume>
          <fpage>917</fpage>
          <lpage>919</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(02)02290-0</pub-id>
          <pub-id pub-id-type="pmid">12788147</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iannaccone</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tedesco</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Gallaher</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Charles</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dryja</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Fundus albipunctatus in a 6-year old girl due to compound heterozygous mutations in the RDH5 gene</article-title>
          <source>Doc Ophthalmol</source>
          <year>2007</year>
          <volume>115</volume>
          <fpage>111</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="doi">10.1007/s10633-007-9054-0</pub-id>
          <pub-id pub-id-type="pmid">17476461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imaizumi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tatewaki</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Kimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nakatsuka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Furushima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Choshi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Disappearance of puncta after uveitis in an eye with fundus albipunctatus</article-title>
          <source>Retina</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>1096</fpage>
          <lpage>1098</lpage>
          <pub-id pub-id-type="doi">10.1097/00006982-200512000-00021</pub-id>
          <pub-id pub-id-type="pmid">16340543</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>J&#xF6;rnvall</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Krook</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Atrian</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gonz&#xE0;lez-Duarte</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jeffery</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Short-chain dehydrogenases/reductases (SDR)</article-title>
          <source>Biochemistry</source>
          <year>1995</year>
          <volume>34</volume>
          <fpage>6003</fpage>
          <lpage>6013</lpage>
          <pub-id pub-id-type="doi">10.1021/bi00018a001</pub-id>
          <pub-id pub-id-type="pmid">7742302</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kanski</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <source>Clinical ophthalmology: a systematic approach</source>
          <year>2003</year>
          <edition>5</edition>
          <publisher-loc>Oxford</publisher-loc>
          <publisher-name>Butterworth-Heinemann</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katsanis</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shroyer</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Cavender</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Al-Rajhi</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Jabak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lupski</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Fundus albipunctatus and retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1</article-title>
          <source>Clin Genet</source>
          <year>2001</year>
          <volume>59</volume>
          <fpage>424</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="doi">10.1034/j.1399-0004.2001.590607.x</pub-id>
          <pub-id pub-id-type="pmid">11453974</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Heinlein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kedishvili</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Palczewski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>PS</given-names>
            </name>
          </person-group>
          <article-title>Delayed dark adaptation in 11-cis-retinol dehydrogenase-deficient mice: a role of RDH11 in visual processes in vivo</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>8694</fpage>
          <lpage>8704</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M413172200</pub-id>
          <pub-id pub-id-type="pmid">15634683</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kranias</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Augsburger</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Resolution of night blindness in fundus albipunctatus</article-title>
          <source>Ann Ophthalmol</source>
          <year>1981</year>
          <volume>13</volume>
          <fpage>871</fpage>
          <lpage>874</lpage>
          <pub-id pub-id-type="pmid">6975055</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Henikoff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>
          <source>Nat Protoc</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>1073</fpage>
          <lpage>1081</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2009.86</pub-id>
          <pub-id pub-id-type="pmid">19561590</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuroiwa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kikuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A novel compound heterozygous mutation in the RDH5 gene in a patient with fundus albipunctatus</article-title>
          <source>Am J Ophthalmol</source>
          <year>2000</year>
          <volume>130</volume>
          <fpage>672</fpage>
          <lpage>675</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(00)00765-0</pub-id>
          <pub-id pub-id-type="pmid">11078852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lid&#xE9;n</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Romert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tryggvason</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Biochemical defects in 11-cis-retinol dehydrogenase mutants associated with fundus albipunctatus</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>49251</fpage>
          <lpage>49257</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M107337200</pub-id>
          <pub-id pub-id-type="pmid">11675386</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sui</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>RDH5 retinopathy (fundus albipunctatus) with preserved rod function</article-title>
          <source>Retina</source>
          <year>2015</year>
          <volume>35</volume>
          <fpage>582</fpage>
          <lpage>589</lpage>
          <pub-id pub-id-type="doi">10.1097/IAE.0000000000000319</pub-id>
          <pub-id pub-id-type="pmid">25170858</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maeda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Palczewski</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Improvement in rod and cone function in mouse model of Fundus albipunctatus after pharmacologic treatment with 9-cis-retinal</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2006</year>
          <volume>47</volume>
          <fpage>4540</fpage>
          <lpage>4546</lpage>
          <pub-id pub-id-type="doi">10.1167/iovs.06-0215</pub-id>
          <pub-id pub-id-type="pmid">17003450</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Makiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ooto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hangai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ogino</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gotoh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Oishi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Cone abnormalities in fundus albipunctatus associated with RDH5 mutations assessed using adaptive optics scanning laser ophthalmoscopy</article-title>
          <source>Am J Ophthalmol</source>
          <year>2014</year>
          <volume>157</volume>
          <fpage>558</fpage>
          <lpage>570</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajo.2013.10.021</pub-id>
          <pub-id pub-id-type="pmid">24246574</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marchler-Bauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Derbyshire</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Gonzales</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chitsaz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Geer</surname>
              <given-names>LY</given-names>
            </name>
            <name>
              <surname>Geer</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gwadz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hurwitz</surname>
              <given-names>DI</given-names>
            </name>
            <name>
              <surname>Lanczycki</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Marchler</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Thanki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>CDD: NCBI&#x2019;s conserved domain database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2015</year>
          <volume>43</volume>
          <issue>Database issue</issue>
          <fpage>D222</fpage>
          <lpage>D226</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gku1221</pub-id>
          <pub-id pub-id-type="pmid">25414356</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsumoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Haen</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Spaide</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>The white dot syndromes</article-title>
          <source>Compr Ophthalmol Update</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>179</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="pmid">17999832</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moiseyev</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>BX</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>JX</given-names>
            </name>
          </person-group>
          <article-title>RPE65 is the isomerohydrolase in the retinoid visual cycle</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>12413</fpage>
          <lpage>12418</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0503460102</pub-id>
          <pub-id pub-id-type="pmid">16116091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Macular dystrophy in a 9-year-old boy with fundus albipunctatus</article-title>
          <source>Am J Ophthalmol</source>
          <year>2002</year>
          <volume>133</volume>
          <fpage>278</fpage>
          <lpage>280</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(01)01304-6</pub-id>
          <pub-id pub-id-type="pmid">11812441</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hotta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tanikawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Terasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2000</year>
          <volume>41</volume>
          <fpage>3925</fpage>
          <lpage>3932</lpage>
          <pub-id pub-id-type="pmid">11053295</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Skalet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>RDH5 gene mutations and electroretinogram in fundus albipunctatus with or without macular dystrophy: RDH5 mutations and ERG in fundus albipunctatus</article-title>
          <source>Doc Ophthalmol</source>
          <year>2003</year>
          <volume>107</volume>
          <fpage>3</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1024498826904</pub-id>
          <pub-id pub-id-type="pmid">12906118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Riazuddin</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Farooq</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Butt</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Zafar</surname>
              <given-names>AU</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Husnain</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Macdonald</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Sieving</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Hejtmancik</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Riazuddin</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Mutations in RLBP1 associated with fundus albipunctatus in consanguineous Pakistani families</article-title>
          <source>Br J Ophthalmol</source>
          <year>2011</year>
          <volume>95</volume>
          <fpage>1019</fpage>
          <lpage>1024</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.2010.189076</pub-id>
          <pub-id pub-id-type="pmid">21447491</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Niwa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Terasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Cone and rod dysfunction in fundus albipunctatus with RDH5 mutation: an electrophysiological study</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>1480</fpage>
          <lpage>1485</lpage>
          <pub-id pub-id-type="doi">10.1167/iovs.04-0638</pub-id>
          <pub-id pub-id-type="pmid">15790919</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oppermann</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Filling</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hult</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shafqat</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lindh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shafqat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nordling</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kallberg</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Persson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>J&#xF6;rnvall</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Short-chain dehydrogenases/reductases (SDR): the 2002 update</article-title>
          <source>Chem Biol Interact</source>
          <year>2003</year>
          <volume>143&#x2013;144</volume>
          <fpage>247</fpage>
          <lpage>253</lpage>
          <pub-id pub-id-type="doi">10.1016/S0009-2797(02)00164-3</pub-id>
          <pub-id pub-id-type="pmid">12604210</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Persson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Krook</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>J&#xF6;rnvall</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Characteristics of short-chain alcohol dehydrogenases and related enzymes</article-title>
          <source>Eur J Biochem</source>
          <year>1991</year>
          <volume>200</volume>
          <fpage>537</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1432-1033.1991.tb16215.x</pub-id>
          <pub-id pub-id-type="pmid">1889416</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pras</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pras</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Reznik-Wolf</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sharon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Raivech</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Barkana</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Abu-Horowitz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ygal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Banin</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Fundus albipunctatus: novel mutations and phenotypic description of Israeli patients</article-title>
          <source>Mol Vis</source>
          <year>2012</year>
          <volume>18</volume>
          <fpage>1712</fpage>
          <lpage>1718</lpage>
          <pub-id pub-id-type="pmid">22815624</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rotenstreich</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Harats</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shaish</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pras</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Belkin</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-{beta}-carotene</article-title>
          <source>Br J Ophthalmol</source>
          <year>2010</year>
          <volume>94</volume>
          <fpage>616</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="doi">10.1136/bjo.2009.167049</pub-id>
          <pub-id pub-id-type="pmid">19955196</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rotenstreich</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Belkin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sadetzki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chetrit</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferman-Attar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sher</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Harari</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shaish</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Harats</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Treatment with 9-cis &#x3B2;-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial</article-title>
          <source>JAMA Ophthalmol</source>
          <year>2013</year>
          <volume>131</volume>
          <fpage>985</fpage>
          <lpage>992</lpage>
          <pub-id pub-id-type="doi">10.1001/jamaophthalmol.2013.147</pub-id>
          <pub-id pub-id-type="pmid">23700011</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>R&#xFC;ther</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>BP</given-names>
            </name>
            <name>
              <surname>Kellner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Bohne</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reimann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Driessen</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Clinical and genetic findings in a patient with fundus albipunctatus</article-title>
          <source>Ophthalmologe</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>177</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1007/s00347-003-0895-y</pub-id>
          <pub-id pub-id-type="pmid">14991316</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oshika</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kaji</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nose</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>A novel homozygous Gly107Arg mutation in the RDH5 gene in a Japanese patient with fundus albipunctatus with sectorial retinitis pigmentosa</article-title>
          <source>Ophthalmic Res</source>
          <year>2004</year>
          <volume>36</volume>
          <fpage>43</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="doi">10.1159/000076109</pub-id>
          <pub-id pub-id-type="pmid">15007239</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schatz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Preising</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eckstein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Lack of autofluorescence in fundus albipunctatus associated with mutations in RDH5</article-title>
          <source>Retina</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>1704</fpage>
          <lpage>1713</lpage>
          <pub-id pub-id-type="doi">10.1097/IAE.0b013e3181dc050a</pub-id>
          <pub-id pub-id-type="pmid">20829743</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schatz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Preising</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sander</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Fundus albipunctatus associated with compound heterozygous mutations in RPE65</article-title>
          <source>Ophthalmology</source>
          <year>2011</year>
          <volume>118</volume>
          <fpage>888</fpage>
          <lpage>894</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2010.09.005</pub-id>
          <pub-id pub-id-type="pmid">21211845</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sekiya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakazawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ohguro</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Usui</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Long-term fundus changes due to Fundus albipunctatus associated with mutations in the RDH5 gene</article-title>
          <source>Arch Ophthalmol</source>
          <year>2003</year>
          <volume>121</volume>
          <fpage>1057</fpage>
          <lpage>1059</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.121.7.1057-b</pub-id>
          <pub-id pub-id-type="pmid">12860821</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sergouniotis</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Sohn</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>McBain</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Robson</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Holder</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Phenotypic variability in RDH5 retinopathy (fundus albipunctatus)</article-title>
          <source>Ophthalmology</source>
          <year>2011</year>
          <volume>118</volume>
          <fpage>1661</fpage>
          <lpage>1670</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2010.12.031</pub-id>
          <pub-id pub-id-type="pmid">21529959</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hellman</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wernstedt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>The retinal pigment epithelial-specific 11-cis retinol dehydrogenase belongs to the family of short chain alcohol dehydrogenases</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>1107</fpage>
          <lpage>1112</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.270.3.1107</pub-id>
          <pub-id pub-id-type="pmid">7836368</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lagercrantz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bajalica-Lagercrantz</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Primary structure of human 11-cis retinol dehydrogenase and organization and chromosomal localization of the corresponding gene</article-title>
          <source>Genomics</source>
          <year>1996</year>
          <volume>36</volume>
          <fpage>424</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1996.0487</pub-id>
          <pub-id pub-id-type="pmid">8884265</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Romert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gustafson</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>McCaffery</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Intracellular localization and membrane topology of 11-cis retinol dehydrogenase in the retinal pigment epithelium suggest a compartmentalized synthesis of 11-cis retinaldehyde</article-title>
          <source>J Cell Sci</source>
          <year>1999</year>
          <volume>112</volume>
          <fpage>549</fpage>
          <lpage>558</lpage>
          <pub-id pub-id-type="pmid">9914166</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sparkes</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Heinzmann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Goldflam</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kojis</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saari</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Mohandas</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Klisak</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Bateman</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Crabb</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Assignment of the gene (RLBP1) for cellular retinaldehyde-binding protein (CRALBP) to human chromosome 15q26 and mouse chromosome 7</article-title>
          <source>Genomics</source>
          <year>1992</year>
          <volume>12</volume>
          <fpage>58</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1016/0888-7543(92)90406-I</pub-id>
          <pub-id pub-id-type="pmid">1733864</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stenson</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Mort</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>DN</given-names>
            </name>
          </person-group>
          <article-title>The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine</article-title>
          <source>Hum Genet</source>
          <year>2014</year>
          <volume>133</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1007/s00439-013-1358-4</pub-id>
          <pub-id pub-id-type="pmid">24077912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Golczak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moise</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Palczewski</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents</article-title>
          <source>Annu Rev Pharmacol Toxicol</source>
          <year>2007</year>
          <volume>47</volume>
          <fpage>469</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.47.120505.105225</pub-id>
          <pub-id pub-id-type="pmid">16968212</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tamai</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A novel Gly35Ser mutation in the RDH5 gene in a Japanese family with fundus albipunctatus associated with cone dystrophy</article-title>
          <source>Arch Ophthalmol</source>
          <year>2001</year>
          <volume>119</volume>
          <fpage>1059</fpage>
          <lpage>1063</lpage>
          <pub-id pub-id-type="doi">10.1001/archopht.119.7.1059</pub-id>
          <pub-id pub-id-type="pmid">11448328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <mixed-citation publication-type="other">Waldron D, Medefindt C (2014) Retina International. Home page at: <ext-link ext-link-type="uri" xlink:href="http://www.retina-international.org/">http://www.retina-international.org</ext-link>. Accessed 25 September 2014</mixed-citation>
      </ref>
      <ref id="CR59">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walia</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Kapur</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Flecked-retina syndromes</article-title>
          <source>Ophthalmic Genet</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>69</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="doi">10.1080/13816810802654516</pub-id>
          <pub-id pub-id-type="pmid">19373677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohishi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hikoya</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Koide</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hotta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Minoshima</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Novel RDH5 mutation in family with mother having fundus albipunctatus and three children with retinitis pigmentosa</article-title>
          <source>Ophthalmic Genet</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>29</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1080/13816810701663535</pub-id>
          <pub-id pub-id-type="pmid">18363170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Chuang</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Yeung</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature</article-title>
          <source>Doc Ophthalmol</source>
          <year>2012</year>
          <volume>125</volume>
          <fpage>51</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1007/s10633-012-9336-z</pub-id>
          <pub-id pub-id-type="pmid">22669287</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Berson</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Dryja</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus</article-title>
          <source>Nat Genet</source>
          <year>1999</year>
          <volume>22</volume>
          <fpage>188</fpage>
          <lpage>191</lpage>
          <pub-id pub-id-type="doi">10.1038/9707</pub-id>
          <pub-id pub-id-type="pmid">10369264</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yakushijin</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kusuhara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Esca&#xF1;o</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Negi</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A novel RDH5 gene mutation in a patient with fundus albipunctatus presenting with macular atrophy and fading white dots</article-title>
          <source>Am J Ophthalmol</source>
          <year>2003</year>
          <volume>136</volume>
          <fpage>572</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9394(03)00332-5</pub-id>
          <pub-id pub-id-type="pmid">12967826</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
